The Joint UNODC-WHO Programme on Drug Dependence Treatment and Care is a collaboration between UNODC and WHO to support the development of comprehensive, integrated health-based approaches to drug policies that can reduce demand for illicit substances, relieve suffering and decrease drug-related harm to individuals, families, communities and societies.

• The promotion and support worldwide (with a particular focus on low- and middle-income countries) of evidence-based policies, strategies and interventions that are based on a public health and human rights approach, in order to reduce drug use and the health and social burden it causes.
• The widespread recognition of drug dependence as a preventable and treatable multifactorial health disorder, and recognition of the social advantages of investing in treatment, such as lowering health-related costs, improving security and contributing to social cohesion and development.
• Drug dependence treatment should become a part of the mainstream health care and social welfare system, without discrimination with respect to other chronic general and mental health disorders. Nothing less than what is provided for other diseases.
• The investment in comprehensive and results-oriented programmes for drug dependence treatment and care, particularly community-based interventions, including the skill set of their human resources.

Brochure about the programme

• Arabic - pdf, 4.99Mb
• Chinese - pdf, 2.64Mb
• English - pdf, 3.42Mb
• French - pdf, 2.26Mb
• Russian - pdf, 2.78Mb
• Spanish - pdf, 2.27Mb

United Nations General Assembly Special Session 2016 on the world drug problem outcome document (A/S-30/L.1) “Our joint commitment to effectively addressing and countering the world drug problem”.

Memorandum of Understanding between the World Health Organization (WHO) and the United Nations Office on Drugs and Crime (UNODC)

• United Nations Office on Drugs and Crime